News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
LaBarre Michael J.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/23/2023 |
4
| LaBarre Michael J. (SVP, CHIEF TECHNICAL OFFICER) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Sold 1,925 shares
@ $42.407, valued at
$81.6k
Sold 8,075 shares
@ $42.407, valued at
$342.4k
Exercised 1,925 options to buy
@ $18.41, valued at
$35.4k
Exercised 8,075 options to buy
@ $19.98, valued at
$161.3k
|
|
| 08/22/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/18/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 04/18/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 02/28/2023 |
4
| LaBarre Michael J. (SVP, CHIEF TECHNICAL OFFICER) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Sold 7,016 shares
@ $49.548, valued at
$347.6k
Sold 2,984 shares
@ $49.549, valued at
$147.9k
|
|
| 02/21/2023 |
4
| LaBarre Michael J. (SVP, CHIEF TECHNICAL OFFICER) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Sold 2,878 shares
@ $49.26, valued at
$141.8k
Exercised 6,112 restricted stock units
@ $0
Granted 48,849 options to buy
@ $49.26, valued at
$2.4M
Granted 17,053 restricted stock units
@ $0 |
|
| 02/14/2023 |
4
| LaBarre Michael J. (SVP, CHIEF TECHNICAL OFFICER) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 2,951 shares
@ $48.92, valued at
$144.4k
Paid exercise price by delivering 2,725 shares
@ $48.92, valued at
$133.3k
Exercised 8,133 restricted stock units
@ $0
Exercised 7,883 restricted stock units
@ $0 |
|
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2022 |
4
| LaBarre Michael J. (SVP, CHIEF TECHNICAL OFFICER) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Sold 4,935 shares
@ $58.671, valued at
$289.5k
Sold 5,065 shares
@ $58.664, valued at
$297.1k
|
|
| 11/16/2022 |
4
| LaBarre Michael J. (SVP, CHIEF TECHNICAL OFFICER) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Sold 6,877 shares
@ $54.12, valued at
$372.2k
Sold 8 shares
@ $54.61, valued at
$436.9
Sold 3,115 shares
@ $54.139, valued at
$168.6k
|
|
| 02/17/2022 |
4
| LaBarre Michael J. (SVP, Chief Technical Officer) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 1,170 shares
@ $34.43, valued at
$40.3k
Exercised 3,386 restricted stock units
@ $0
Granted 74,777 options to buy
@ $34.36, valued at
$2.6M
Granted 24,448 restricted stock units
@ $0 |
|
| 02/14/2022 |
4
| LaBarre Michael J. (SVP, Chief Technical Officer) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 2,992 shares
@ $34.94, valued at
$104.5k
Paid exercise price by delivering 2,725 shares
@ $34.2, valued at
$93.2k
Paid exercise price by delivering 1,995 shares
@ $33.64, valued at
$67.1k
Exercised 8,133 restricted stock units
@ $0
Exercised 7,883 restricted stock units
@ $0
Exercised 5,771 restricted stock units
@ $0 |
|
| 10/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2021 |
4
| LaBarre Michael J. (SVP, Chief Technical Officer) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Sold 40,315 shares
@ $45.698, valued at
$1.8M
Exercised 40,315 options to buy
@ $6.55, valued at
$264.1k
|
|
| 05/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/21/2020 |
4
| LaBarre Michael J. (SVP, Chief Technical Officer) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Sold 11,400 shares
@ $42.541, valued at
$485k
Sold 600 shares
@ $43.252, valued at
$26k
|
|
| 11/20/2020 |
4
| LaBarre Michael J. (SVP, Chief Technical Officer) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Sold 4,111 shares
@ $38.244, valued at
$157.2k
Sold 7,889 shares
@ $39.036, valued at
$308k
|
|
| 10/20/2020 |
4
| LaBarre Michael J. (SVP, Chief Technical Officer) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Sold 12,000 shares
@ $30.429, valued at
$365.1k
|
|
| 09/21/2020 |
4
| LaBarre Michael J. (SVP, Chief Technical Officer) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Sold 12,000 shares
@ $26.907, valued at
$322.9k
|
|
| 08/20/2020 |
4
| LaBarre Michael J. (SVP, Chief Technical Officer) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Sold 12,000 shares
@ $28.297, valued at
$339.6k
|
|
| 07/20/2020 |
4
| LaBarre Michael J. (SVP, Chief Technical Officer) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Sold 12,000 shares
@ $29.006, valued at
$348.1k
|
|
| 05/22/2020 |
4
| LaBarre Michael J. (SVP, Chief Technical Officer) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Exercised 18,613 options to buy
@ $7.14, valued at
$132.9k
|
|
| 05/21/2020 |
4
| LaBarre Michael J. (SVP, Chief Technical Officer) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Sold 21,387 shares
@ $23.803, valued at
$509.1k
Exercised 21,387 options to buy
@ $7.14, valued at
$152.7k
|
|
|
|
|